Journal article
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
- Schünemann HJ McMaster University, Hamilton, Ontario, Canada (H.J.S.).
- Lerda D European Commission, Joint Research Centre, Ispra, Italy (D.L., E.P., Z.S.).
- Quinn C St. Vincent's University Hospital, Dublin, Ireland (C.Q.).
- Follmann M German Cancer Society, Berlin, Germany (M.F.).
- Alonso-Coello P Iberoamerican Cochrane Center, Barcelona, Spain (P.A.).
- Rossi PG Azienda Unitá Sanitaria Locale-IRCCS di Reggio Emilia, Reggia Emilia, Italy (P.G.R.).
- Lebeau A Private Group Practice for Pathology, Lübeck, Germany (A.L.).
- Nyström L Umeå University, Umeå, Sweden (L.N.).
- Broeders M Radboud University Medical Centre, Nijmegen, the Netherlands (M.B.).
- Ioannidou-Mouzaka L University of Athens Medical School, Athens, Greece (L.I.).
- Duffy SW Queen Mary University of London, London, United Kingdom (S.W.D.).
- Borisch B University of Geneva, Geneva, Switzerland (B.B.).
- Fitzpatrick P National Screening Service, Dublin, Ireland (P.F.).
- Hofvind S Cancer Registry of Norway, Oslo, Norway (S.H.).
- Castells X IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain (X.C.).
- Giordano L CPO-Piedmont - AOU Cittá della Salute e della Scienza, Torino, Italy (L.G.).
- Canelo-Aybar C Iberoamerican Cochrane Centre, Barcelona, Spain (C.C.).
- Warman S Langford, North Somerset, United Kingdom (S.W.).
- Mansel R Cardiff University, Cardiff, United Kingdom (R.M.).
- Sardanelli F Universitá degli Studi di Milano, Milan, Italy (F.S.).
- Parmelli E European Commission, Joint Research Centre, Ispra, Italy (D.L., E.P., Z.S.).
- Gräwingholt A Radiologie am Theater, Paderborn, Germany (A.G.).
- Saz-Parkinson Z European Commission, Joint Research Centre, Ispra, Italy (D.L., E.P., Z.S.).
- 2019-11-26
Published in:
- Annals of internal medicine. - 2020
Adult
Age Factors
Aged
Breast Neoplasms
Early Detection of Cancer
Europe
Female
Humans
Mammography
Middle Aged
Ultrasonography, Mammary
English
Description
The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers.
Methods
An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence.
Recommendations
This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.
The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers.
Methods
An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence.
Recommendations
This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.7326/M19-2125
- PMID 31766052
- Persistent URL
- https://sonar.ch/global/documents/34355
Statistics
Document views: 69
File downloads: